Quantitative assessment of the influence of PPARG P12A polymorphism on gestational diabetes mellitus risk

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 811-817

  Wang, Caiyan ^a   Li, Xiaotian ^a   Huang, Zirong ^a   Qian, Jinfeng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Gestational diabetes mellitus; Meta analysis; Polymorphism; PPARG

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALLELE; ARAB; ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; PPARG GENE; PREGNANCY; PREGNANCY DIABETES MELLITUS; QUANTITATIVE ANALYSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SYSTEMATIC REVIEW;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PPAR GAMMA; PREGNANCY; PUBLICATION BIAS; RISK;

EID: 84878359700     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2119-5     Document Type: Article

References (32)

1. Metzger BE, Coustan DR (1998) Summary and recommendations of the fourth international workshop-conference on gestational diabetes mellitus. Diabetes Care 21(Suppl 2):B161-B167
2. Aberg A, Rydhstroem H, Frid A (2001) Impaired glucose tolerance associated with adverse pregnancy outcome: a population-based study in Southern Sweden. Am J Obstet Gynecol 184:77-83
3. King H (1998) Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care 21(Suppl 2):B9-B13
4. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM (2004) An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol 103:526-533
5. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS (2005) Increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM Screening Program. Diabetes Care 28:579-584
6. HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR et al (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991-2002
7. Löbner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E, Ziegler AG (2006) Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 55:792-797
8. Bellamy L, Casas JP, Hingorani AD, Williams D (2009) Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 373:1773-1779
9. Michalik L, Auwerx J, Berger JP et al (2006) International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors. Pharmacol Rev 58:726-741
10. Spiegelman BM (1998) PPAR-c: adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514
11. Dubuquoy L, Dharancy S, Nutten S et al (2002) Role of peroxisome proliferator-activated receptor c and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360:1410-1418
12. Mukherjee R, Jow L, Croston GE et al (1997) Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARc2 versus PPARc1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 272:8071-8076
13. Fajas L, Debril MB, Auwerx J (2001) PPAR: an essential role in metabolic control. Nutr Metab Cardiovasc Dis 11:64-69
14. Deeb SS, Fajas L, Nemoto M et al (1998) A Pro12Ala substitution in PPAR2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
15. Doney AS, Fischer B, Cecil JE, Boylan K, McGuigan FE, Ralston SH, Morris AD, Palmer CN (2004) Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to type 2 diabetes. Diabetologia 47:555-558
16. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Lebel P, Dallongeville J, Deeb S, Auwerx J, Amouyel P (1998) A genetic polymorphism of the peroxisome proliferator-activated receptor gene influences plasma leptin levels in obese humans. Hum Mol Genet 7:435-440
17. Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10:101-129
18. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
19. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
20. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629-634
21. Heude B, Pelloux V, Forhan A et al (2011) Association of the Pro12Ala and C1431T variants of PPARgamma and their haplotypes with susceptibility to gestational diabetes. J Clin Endocrinol Metab 96:E1656-E1660
22. Pappa KI, Gazouli M, Economou K et al (2011) Gestational diabetes mellitus shares polymorphisms of genes associated with insulin resistance and type 2 diabetes in the Greek population. Gynecol Endocrinol 27:267-272
23. Cheng Y, Ma Y, Peng T, Wang J, Lin R, Cheng HD (2010) Genotype discrepancy between maternal and fetal Pro12Ala polymorphism of PPARG2 gene and its association with gestational diabetes mellitus. Zhonghua Fu Chan Ke Za Zhi 45:170-173
24. Cho YM, Kim TH, Lim S et al (2009) Type 2 diabetes-associated genetic variants discovered in the recent genome-wide association studies are related to gestational diabetes mellitus in the Korean population. Diabetologia 52:253-261
25. Zhu Y, Wu Y (2009) Relationship between Prol2Ala polymorphism in peroxisome proliferators-activated receptor gamma 2 gene and gestational diabetes mellitus. Shi Yong Yi Xue Za Zhi 25:1963-1965 (in Chinese)
26. Lauenborg J, Grarup N, Damm P et al (2009) Common type 2 diabetes risk gene variants associate with gestational diabetes. J Clin Endocrinol Metab 94:145-150
27. Shaat N, Lernmark A, Karlsson E et al (2007) A variant in the transcription factor 7-like 2 (TCF7L2) gene is associated with an increased risk of gestational diabetes mellitus. Diabetologia 50:972-979
28. Tok EC, Ertunc D, Bilgin O, Erdal EM, Kaplanoglu M, Dilek S (2006) PPAR-gamma2 Pro12Ala polymorphism is associated with weight gain in women with gestational diabetes mellitus. Eur J Obstet Gynecol Reprod Biol 129:25-30
29. Shaat N, Ekelund M, Lernmark A et al (2004) Genotypic and phenotypic differences between Arabian and Scandinavian women with gestational diabetes mellitus. Diabetologia 47:878-884
30. Altshuler D, Hirschhorn JN, Klannemark M et al (2000) The common PPAR Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
31. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182
32. Tönjes A, Scholz M, Loeffler M, Stumvoll M (2006) Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. Diabetes Care 29:2489-2497